Join us Sept. 14-16 in Miami to connect with top publishing leaders
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
Creators are moving into brands’ AI search playbooks
As brands race to show up in AI-generated answers, creators are becoming part of the strategy.
Target plans to lower prices after receiving almost $1 billion in tariff refunds
Tariff refunds were a massive tailwind for Target last quarter that could help it continue to lower prices.
OpenAI’s ads business hits Europe at the six month mark
OpenAI will begin serving ads to people using ChatGPT across 31 European markets beginning August 24.